| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |